McAdam LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $267K | Buy |
600
+84
| +16% | +$37.4K | 0.01% | 312 |
|
2025
Q1 | $250K | Sell |
516
-1,679
| -76% | -$814K | 0.02% | 288 |
|
2024
Q4 | $884K | Sell |
2,195
-441
| -17% | -$178K | 0.05% | 146 |
|
2024
Q3 | $1.23M | Buy |
2,636
+116
| +5% | +$53.9K | 0.07% | 118 |
|
2024
Q2 | $1.18M | Buy |
2,520
+488
| +24% | +$229K | 0.07% | 109 |
|
2024
Q1 | $849K | Buy |
2,032
+35
| +2% | +$14.6K | 0.05% | 127 |
|
2023
Q4 | $813K | Sell |
1,997
-170
| -8% | -$69.2K | 0.06% | 123 |
|
2023
Q3 | $754K | Buy |
2,167
+4
| +0.2% | +$1.39K | 0.06% | 130 |
|
2023
Q2 | $761K | Sell |
2,163
-60
| -3% | -$21.1K | 0.06% | 126 |
|
2023
Q1 | $700K | Sell |
2,223
-731
| -25% | -$230K | 0.06% | 128 |
|
2022
Q4 | $649K | Buy |
2,954
+186
| +7% | +$40.9K | 0.06% | 92 |
|
2022
Q3 | $801K | Buy |
2,768
+5
| +0.2% | +$1.45K | 0.09% | 106 |
|
2022
Q2 | $779K | Sell |
2,763
-170
| -6% | -$47.9K | 0.08% | 108 |
|
2022
Q1 | $765K | Sell |
2,933
-21
| -0.7% | -$5.48K | 0.07% | 91 |
|
2021
Q4 | $649K | Sell |
2,954
-385
| -12% | -$84.6K | 0.06% | 92 |
|
2021
Q3 | $606K | Buy |
3,339
+1,419
| +74% | +$258K | 0.07% | 88 |
|
2021
Q2 | $385K | Buy |
1,920
+210
| +12% | +$42.1K | 0.04% | 115 |
|
2021
Q1 | $367K | Hold |
1,710
| – | – | 0.05% | 106 |
|
2020
Q4 | $401K | Buy |
1,710
+679
| +66% | +$159K | 0.06% | 99 |
|
2020
Q3 | $281K | Buy |
1,031
+10
| +1% | +$2.73K | 0.05% | 104 |
|
2020
Q2 | $296K | Sell |
1,021
-34
| -3% | -$9.86K | 0.06% | 88 |
|
2020
Q1 | $251K | Buy |
1,055
+34
| +3% | +$8.09K | 0.07% | 83 |
|
2019
Q4 | $224K | Buy |
+1,021
| New | +$224K | 0.05% | 79 |
|
2019
Q3 | – | Sell |
-1,162
| Closed | -$213K | – | 87 |
|
2019
Q2 | $213K | Hold |
1,162
| – | – | 0.06% | 70 |
|
2019
Q1 | $214K | Sell |
1,162
-108
| -9% | -$19.9K | 0.07% | 66 |
|
2018
Q4 | $210K | Hold |
1,270
| – | – | 0.08% | 60 |
|
2018
Q3 | $244K | Buy |
1,270
+1,168
| +1,145% | +$224K | 0.09% | 53 |
|
2018
Q2 | $17K | Sell |
102
-848
| -89% | -$141K | 0.01% | 268 |
|
2018
Q1 | $155K | Buy |
+950
| New | +$155K | 0.07% | 72 |
|